Form 4: Inspire Medical Systems Director Acquires Shares in Lieu of Cash Fees

Casey M. Tansey, a director at Inspire Medical Systems, acquired 81 shares of common stock in lieu of cash fees on January 15, 2025.

Summary

• Casey M. Tansey, a director at Inspire Medical Systems, acquired 81 shares of common stock on January 15, 2025.
• The shares were received in lieu of cash fees, as per the company's Non-Employee Director Compensation Policy.
• The acquisition price was $176.33 per share.
• Following the transaction, Tansey directly owns 20,512 shares.
• Tansey also indirectly owns 500 shares through The Kimberly Tansey Irrevocable Trust and 500 shares through The Kylie Tansey Irrevocable Trust.

Sentiment

Score: 7

Explanation: The sentiment is neutral to slightly positive as it reflects a director's continued investment in the company, but it's a routine transaction.

Positives

• The acquisition of shares by a director demonstrates confidence in the company's future.
• The use of stock in lieu of cash fees can be seen as a positive for the company's cash flow.

Industry Context

This is a routine filing related to insider transactions and is common for publicly traded companies. It does not indicate any specific trend in the medical device industry.

Comparison to Industry Standards

• Form 4 filings are standard practice for publicly traded companies, and this transaction is consistent with typical director compensation practices.
• Many companies use stock-based compensation for directors to align their interests with shareholders.

Stakeholder Impact

• The transaction has a minor positive impact on shareholders as it aligns director interests with company performance.

Key Dates

Keywords

Insider Trading, Form 4, Director, Share Acquisition, Equity, Inspire Medical Systems, INSP